Hot Pursuit     04-Nov-24
Sun Pharma tumbles after US court halts Leqselvi launch
Sun Pharmaceutical Industries slipped 4.30% to 1,778.85 after the US District Court of New Jersey has decided to grant a preliminary injunction delaying the launch of Leqselvi (Baldness treatment) in the US.
Aa result of the court's decision, Sun Pharma has been temporarily barred from launching Leqselvi until a subsequent favorable court decision or until the expiry of patent in lawsuit, whichever is earlier, it added.

Earlier on 1 August 2024, the pharma major had informed that it filed a motion seeking a preliminary injunction in a US court to prevent the launch of LEQSELVI.

Sun Pharmaceuticals Industries is a leading global pharmaceutical company with specialty and generic presence and India's top pharma company.

The company’s consolidated net profit jumped 27.97% to Rs 3,040.16 crore on 9.01% rise in revenue from operations to Rs 13,291.39 crore in Q2 FY25 over Q2 FY24.

Previous News
  Sun Pharmaceuticals Industries announces board meeting date
 ( Corporate News - 12-May-25   15:56 )
  Sun Pharmaceutical Industries Ltd eases for fifth straight session
 ( Hot Pursuit - 12-May-25   13:35 )
  Sun Pharmaceutical Industries Ltd Slips 5.32%
 ( Hot Pursuit - 12-May-25   09:30 )
  Sun Pharma and Israel-based Moebius Medical publish two articles on MM-II
 ( Corporate News - 24-Apr-25   09:12 )
  Sun Pharma receives favourable ruling in preliminary injunction delaying launch of LEQSELVI™
 ( Corporate News - 10-Apr-25   13:21 )
  Sun Pharma launches Fexuprazan tablets 40 mg in India
 ( Hot Pursuit - 07-Apr-25   10:23 )
  Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India
 ( Corporate News - 07-Apr-25   09:07 )
  Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada
 ( Corporate News - 18-Mar-25   15:01 )
  Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million
 ( Hot Pursuit - 18-Mar-25   12:53 )
  Sun Pharmaceuticals Industries Ltd soars 0.96%, gains for fifth straight session
 ( Hot Pursuit - 17-Mar-25   13:00 )
  Sun Pharmaceuticals Industries Ltd rises for third straight session
 ( Hot Pursuit - 12-Mar-25   13:05 )
Other Stories
  Piramal Pharma gains after receiving EIR for Turbhe facility from USFDA
  12-May-25   15:39
  Man Industries hits the roof after PAT rises nearly 3x YoY to Rs 68 crore in Q4
  12-May-25   15:39
  Wanbury spurts after Tanuku facility clears ANVISA inspection with zero observations
  12-May-25   15:25
  K P R Mill Ltd leads losers in 'A' group
  12-May-25   15:00
  Bajaj Electricals soars after strong Q4 performance
  12-May-25   14:51
  Dr Reddys Lab jumps after Q4 PAT rises 22% YoY
  12-May-25   14:50
  Premier Explosives Ltd leads losers in 'B' group
  12-May-25   14:45
  Venkys (India) slides after Q4 PAT tumble 60% YoY to Rs 13 cr
  12-May-25   14:44
  TFCI jumps after Q4 PAT rises 48% YoY to Rs 30 cr
  12-May-25   14:36
  Volumes soar at C.E. Info Systems Ltd counter
  12-May-25   14:30
Back Top